Procter & Gamble Q4 Earnings Miss Revenue Estimates, Post Positive EPS Beat

PG's fiscal fourth-quarter results split depending on which number investors watched. Core earnings per share of $1.43 beat the $1.41 analyst consensus, while GAAP diluted EPS fell 15% year over year to $1.26 as higher SG&A costs and lower gross margin outpaced the sales gain . Net sales of $21.2 billion missed Street expectations near $21.38 billion, and organic sales were flat versus a year ago .

CFO Andre Schulten said P&G delivered its highest productivity number in about a decade during the quarter, a sign of cost discipline amid uneven demand. Beauty led all segments with 3% volume growth, while health care volume fell 3% on softer oral care demand and grooming volume slipped 1% .

For fiscal 2027, P&G guided to organic sales growth of 1-3% and core EPS of $6.89 to $7.11, a midpoint of $7.00 that is about 1.5% above fiscal 2026's $6.89 core EPS but slightly below the $7.02 analyst consensus. Management flagged roughly $1 billion in after-tax commodity, energy and transportation cost headwinds for the year.

Shares fell more than 3% on the report as investors focused on the sales miss and cautious guidance over the EPS beat, a pattern this earnings season in which consumer-staples peers have leaned on pricing and mix rather than volume for growth.

Related Stocks

• PG